217 related articles for article (PubMed ID: 32927496)
1. Insights Into the Controversial Aspects of Adiponectin in Cardiometabolic Disorders.
Francischetti EA; Dezonne RS; Pereira CM; de Moraes Martins CJ; Celoria BMJ; de Oliveira PAC; de Abreu VG
Horm Metab Res; 2020 Oct; 52(10):695-707. PubMed ID: 32927496
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin and adiponectin receptors in obesity-linked insulin resistance.
Kadowaki T; Yamauchi T; Kubota N; Hara K; Ueki K
Novartis Found Symp; 2007; 286():164-76; discussion 176-82, 200-3. PubMed ID: 18269182
[TBL] [Abstract][Full Text] [Related]
3. The role of leptin/adiponectin ratio in metabolic syndrome and diabetes.
López-Jaramillo P; Gómez-Arbeláez D; López-López J; López-López C; Martínez-Ortega J; Gómez-Rodríguez A; Triana-Cubillos S
Horm Mol Biol Clin Investig; 2014 Apr; 18(1):37-45. PubMed ID: 25389999
[TBL] [Abstract][Full Text] [Related]
4. Modulation of adiponectin as a potential therapeutic strategy.
Lim S; Quon MJ; Koh KK
Atherosclerosis; 2014 Apr; 233(2):721-728. PubMed ID: 24603219
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin and cardiovascular disease: state of the art?
Szmitko PE; Teoh H; Stewart DJ; Verma S
Am J Physiol Heart Circ Physiol; 2007 Apr; 292(4):H1655-63. PubMed ID: 17142348
[TBL] [Abstract][Full Text] [Related]
6. Protective role of adiponectin in cardiovascular disease.
Shibata R; Murohara T; Ouchi N
Curr Med Chem; 2012; 19(32):5459-66. PubMed ID: 22876923
[TBL] [Abstract][Full Text] [Related]
7. The role of adiponectin signaling in metabolic syndrome and cancer.
Scheid MP; Sweeney G
Rev Endocr Metab Disord; 2014 Jun; 15(2):157-67. PubMed ID: 24019064
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin: A potential therapeutic target for metabolic syndrome.
Ghadge AA; Khaire AA; Kuvalekar AA
Cytokine Growth Factor Rev; 2018 Feb; 39():151-158. PubMed ID: 29395659
[TBL] [Abstract][Full Text] [Related]
9. Adiponectin in diabetes mellitus.
Xita N; Tsatsoulis A
Curr Med Chem; 2012; 19(32):5451-8. PubMed ID: 22876922
[TBL] [Abstract][Full Text] [Related]
10. Roles of oxidative stress, adiponectin, and nuclear hormone receptors in obesity-associated insulin resistance and cardiovascular risk.
Matsuda M; Shimomura I
Horm Mol Biol Clin Investig; 2014 Aug; 19(2):75-88. PubMed ID: 25390017
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction.
Achari AE; Jain SK
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28635626
[TBL] [Abstract][Full Text] [Related]
12. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases.
Yamauchi T; Kadowaki T
Int J Obes (Lond); 2008 Dec; 32 Suppl 7():S13-8. PubMed ID: 19136982
[TBL] [Abstract][Full Text] [Related]
13. Adiponectin: merely a bystander or the missing link to cardiovascular disease?
Hatzis G; Deftereos S; Tousoulis D; Bouras G; Giannopoulos G; Anatoliotakis N; Tsounis D; Stefanadis C
Curr Top Med Chem; 2013; 13(2):139-63. PubMed ID: 23470075
[TBL] [Abstract][Full Text] [Related]
14. Roles of adiponectin and oxidative stress in obesity-associated metabolic and cardiovascular diseases.
Matsuda M; Shimomura I
Rev Endocr Metab Disord; 2014 Mar; 15(1):1-10. PubMed ID: 24026768
[TBL] [Abstract][Full Text] [Related]
15. [The adiponectin to leptin ratio, a still unrecognized biomarker of insulin resistance and cardiometabolic risk].
Vatier C; Antuna-Puente B; Fellahi S; Vigouroux C; Capeau J; Bastard JP;
Ann Biol Clin (Paris); 2020 Jun; 78(3):265-268. PubMed ID: 32420886
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin and end-stage renal disease.
Markaki A; Psylinakis E; Spyridaki A
Hormones (Athens); 2016 Jul; 15(3):345-354. PubMed ID: 27838604
[TBL] [Abstract][Full Text] [Related]
17. Exploring the Cardio-metabolic Relevance of T-cadherin: A Pleiotropic Adiponectin Receptor.
Clark JL; Taylor CG; Zahradka P
Endocr Metab Immune Disord Drug Targets; 2017; 17(3):200-206. PubMed ID: 28820074
[TBL] [Abstract][Full Text] [Related]
18. Adiponectin: a key adipocytokine in metabolic syndrome.
Okamoto Y; Kihara S; Funahashi T; Matsuzawa Y; Libby P
Clin Sci (Lond); 2006 Mar; 110(3):267-78. PubMed ID: 16464169
[TBL] [Abstract][Full Text] [Related]
19. Adiponectin-leptin ratio: A promising index to estimate adipose tissue dysfunction. Relation with obesity-associated cardiometabolic risk.
Frühbeck G; Catalán V; Rodríguez A; Gómez-Ambrosi J
Adipocyte; 2018 Jan; 7(1):57-62. PubMed ID: 29205099
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin: mechanistic insights and clinical implications.
Turer AT; Scherer PE
Diabetologia; 2012 Sep; 55(9):2319-26. PubMed ID: 22688349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
